Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 4 Prostatic Neoplasms 2 Multiple Myeloma 2 Melanoma 2 Kidney Neoplasms 2 Head and Neck Neoplasms 2 Breast Neoplasms 2 Waldenstrom Macroglobulinemia 1 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Tongue Neoplasms 1 Thyroid Neoplasms 1 Thymus Neoplasms 1 Testicular Neoplasms 1 Substance-Related Disorders 1 Stomach Neoplasms 1 Skin Neoplasms 1 Sarcoma, Synovial 1 Sarcoma, Kaposi 1 Sarcoma 1 Salivary Gland Neoplasms 1 Rectal Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pheochromocytoma 1 Pharyngeal Neoplasms 1 Penile Neoplasms 1

Interventions

pazopanib 2 Sunitinib 2 Sorafenib 2 Bevacizumab 2 Radiation Dose Hypofractionation 1 Patient Reported Outcome Measures 1 Methods 1 Medical Records 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Financial Stress × Patient Reported Outcome Measures × Clear all

NCT05319925 2023-12-15

FIAT

University Hospital Heidelberg

Financial Stress, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡